Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 31.05.2014

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
31.05.14FRC Responds to Reports Meriam Ibrahim May Be Released from Sudan's Death Row, Urges Safe Haven in U.S.170WASHINGTON, May 31, 2014 /PRNewswire-USNewswire/ --Family Research Council President (FRC) Tony Perkins responded today to reports that the Sudan government may release Meriam Ibrahim from death row...
► Artikel lesen
31.05.14Foresters, KaBOOM! and volunteers bring families together with new playground in Greensboro150Playground will enhance family and community well-being GREENSBORO, NC, May 31, 2014 /PRNewswire/ - The Greensboro community was revitalized today thanks to a new playground built at Camp Weaver....
► Artikel lesen
31.05.14Foresters, KaBOOM! and volunteers bring families together with new playground in Prince George's County156Playground will enhance family and community well-being LANHAM, MD, May 31, 2014 /PRNewswire/ -Prince George's County community was revitalized today thanks to a new playground built at Seabrook...
► Artikel lesen
31.05.14Markey Addresses Bunker Hill Community College Commencement Exercises175BOSTON, May 31, 2014 /PRNewswire-USNewswire/ --U.S. Senator Edward J. Markey delivered the keynote address today at the 40th Commencement exercises at Bunker Hill Community College (BHCC). A record-breaking...
► Artikel lesen
31.05.14Positive Data from Phase 2 Trial of Nektar Therapeutics' NKTR-102 in Patients with Avastin-Refractory High-Grade Glioma Presented at 50th ASCO Meeting189SAN FRANCISCO, May 31, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with...
► Artikel lesen
31.05.14Cash Store Financial Announces Cease Trade Order Issued by Alberta Securities Commission17EDMONTON, May 31, 2014 /PRNewswire/ - The Cash Store Financial Services Inc. ("Cash Store Financial" or the "Company") announced today that a Cease Trade Order (the "Cease Trade Order") was issued...
► Artikel lesen
31.05.14Ronald McDonald House Charities Of Southern California Helps High School Seniors Fund Their Higher Education By Awarding $338,000 In College Scholarships25LOS ANGELES, May 31, 2014 /PRNewswire/ -- Today, Ronald McDonald House Charities® (RMHC) of Southern California awarded $338,000 in scholarship funds to 111 exceptional high school seniors from Los...
► Artikel lesen
31.05.14Benzene Consumption Market worth 53,432.9 Kilotons by 201825DALLAS, May 31, 2014 /PRNewswire/ -- The report"Benzene Market & Its Derivatives(Ethylbenzene, Cumene, Cyclohexane, Nitrobenzene, and Alkylbenzene) Market by Application & Geography-Trends and Forecasts...
► Artikel lesen
31.05.14Statewide Charter School Movement Mobilizes Unprecedented Strength To Preserve, Promote Quality Schools In Illinois78CHICAGO, May 31, 2014 /PRNewswire-USNewswire/ -- With the conclusion of the 2014 Illinois legislative session just minutes ago, the Illinois Network of Charter Schools (INCS) recognizes the leadership...
► Artikel lesen
31.05.14Investigational Drug AZD9291 Shows Clinical Responses in Patients With Advanced NSCLC Who Have Previously Failed on Established EGFR TKIs67CHICAGO, May 31, 2014 /PRNewswire/ -- Data from the ongoing Phase I AURA study in patients with epidermal growth factor receptor mutation positive (EGFRm+), advanced non-small cell lung cancer (NSCLC)...
► Artikel lesen
31.05.14Ooredoo Launches Global Campaign with Leo Messi31DOHA, Qatar, May 31, 2014 /PRNewswire/ -- Ooredoo today launch its first-ever global communication campaign with brand ambassador Leo Messi, as the company reaches out to football fans and social...
► Artikel lesen
31.05.14Barbie welcomes internationally renowned actress, Fan Bing Bing, to shine in her global Hall of Fame debut54SHANGHAI, May 31, 2014 /PRNewswire/ -- Launch of Barbie Fan Bing Bing Celebrity Specialty doll. She joins Barbie in inspiring young girls to "Shine Your Way". 2014 will marks the 55th anniversary...
► Artikel lesen
31.05.14Remember the Removal Bike Riders Retrace Cherokee History47CHEROKEE, N.C., May 31, 2014 /PRNewswire/ -- Six members of the Eastern Band of Cherokee Indians joined 12 members of the Cherokee Nation from Oklahoma in the annual 950-mile, "Remember the Removal"...
► Artikel lesen
31.05.14Amines Market, Phthalic Anhydride and Derivatives 2018 Forecasts27DALLAS, May 31, 2014 /PRNewswire/ -- RnRMarketResearch.com offers Amines Market By Type (Ethanolamines, Alkylamines, Fatty Amines, Specialty Amines And Ethylene Amines), By Application (Agricultural...
► Artikel lesen
31.05.14IMBRUVICA (ibrutinib) Combination with anti CD20 Antibody Shows Compelling Results in Heavily Pretreated Patients with CLL and Related Diseases25SUNNYVALE, Calif., May 31, 2014 /PRNewswire/ --Pharmacyclics, Inc. (NASDAQ: PCYC) announced today that IMBRUVICA®(ibrutinib) in combination with the anti-CD20 antibody, ofatumumab, showed a Kaplan...
► Artikel lesen
31.05.14IMBRUVICA (ibrutinib) Shows Durable, Long-Term Responses for Patients with CLL27SUNNYVALE, Calif., May 31, 2014 /PRNewswire/ --Pharmacyclics, Inc. (NASDAQ: PCYC) announced today that IMBRUVICA®(ibrutinib) will be featured in an oral presentation...
► Artikel lesen
31.05.14IMBRUVICA (ibrutinib) Significantly Improves Progression Free Survival, Overall Survival and Overall Response as compared to Ofatumumab in Patients with Previously Treated CLL/SLL in its First Phase III study21SUNNYVALE, Calif., May 31, 2014 /PRNewswire/ --Pharmacyclics, Inc. (NASDAQ: PCYC) today announced trial results of the first Phase III study (RESONATE, PCYC-1112-CA), a head-to-head comparison of...
► Artikel lesen
31.05.14PROCLAIM(SM) National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2)38CHICAGO, May 31, 2014 /PRNewswire/ --Prometheus Laboratories Inc. announced today that data from the PROCLAIMSM national patient registry retrospective cohort document an improvement in median overall...
► Artikel lesen
31.05.14Castle Biosciences' Esophageal Cancer Test Accurately Predicts Pre-Surgical Treatment Response33CHICAGO, May 31, 2014 /PRNewswire/ --Castle Biosciences Inc. today announced study results from its proprietary multi-analyte test DecisionDx-EC, which is designed to determine which patients with...
► Artikel lesen
31.05.14Amgen Highlights Phase 2 Results Of Vectibix (panitumumab) Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer41THOUSAND OAKS, Calif., May 31, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from the Phase 2 PEAK study that reinforce the improved overall survival (OS) benefit of panitumumab...
► Artikel lesen
Seite:  Weiter >>